MoneyWorks4Me

USFDA completes audit at Dr. Reddy’s API Hyderabad plant

16 Mar 2018 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Hyderabad plant I at Jinnaram Mandal, Medak District, Telangana on March 16, 2018. USFDA has issued a Form 483 with four observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..